PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
56 hedge funds and large institutions have $58.1M invested in Poseida Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
46% less capital invested
Capital invested by funds: $107M → $58.1M (-$49.2M)
Holders
56
Holding in Top 10
1
Calls
$5K
Puts
–
Top Buyers
| 1 | +$1.41M | |
| 2 | +$498K | |
| 3 | +$459K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$364K |
| 5 |
E
Ergoteles
New York
|
+$352K |
Top Sellers
| 1 | -$3.49M | |
| 2 | -$1.3M | |
| 3 | -$1.13M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$620K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$485K |